Empagliflozin treatment differentially modifies visceral and subcutaneous adipose tissue lipidomes and pro-inflammatory cytokines in zucker fatty diabetic rats.
Event:
ESC Congress 2022
Topic:
Metabolism
Session:
Metabolism, mitochondria, and heart diseases
